Resonant Capital Advisors LLC Has $820,000 Position in UnitedHealth Group Incorporated $UNH

Resonant Capital Advisors LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,628 shares of the healthcare conglomerate’s stock after selling 367 shares during the period. Resonant Capital Advisors LLC’s holdings in UnitedHealth Group were worth $820,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. New Hampshire Trust boosted its position in shares of UnitedHealth Group by 14.1% during the 2nd quarter. New Hampshire Trust now owns 937 shares of the healthcare conglomerate’s stock valued at $292,000 after purchasing an additional 116 shares in the last quarter. Prudent Man Advisors LLC boosted its holdings in UnitedHealth Group by 34.2% in the second quarter. Prudent Man Advisors LLC now owns 3,659 shares of the healthcare conglomerate’s stock worth $1,141,000 after acquiring an additional 932 shares in the last quarter. VestGen Investment Management boosted its holdings in UnitedHealth Group by 17.0% in the second quarter. VestGen Investment Management now owns 723 shares of the healthcare conglomerate’s stock worth $226,000 after acquiring an additional 105 shares in the last quarter. University of Texas Texas AM Investment Management Co. boosted its holdings in UnitedHealth Group by 719.7% in the second quarter. University of Texas Texas AM Investment Management Co. now owns 7,025 shares of the healthcare conglomerate’s stock worth $2,192,000 after acquiring an additional 6,168 shares in the last quarter. Finally, Interchange Capital Partners LLC boosted its holdings in UnitedHealth Group by 49.5% in the second quarter. Interchange Capital Partners LLC now owns 6,611 shares of the healthcare conglomerate’s stock worth $2,063,000 after acquiring an additional 2,190 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on UNH. Oppenheimer cut their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. The Goldman Sachs Group initiated coverage on UnitedHealth Group in a report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 target price on the stock. Piper Sandler dropped their target price on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Finally, Royal Bank Of Canada dropped their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Eighteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $385.13.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $362.78 on Monday. The business’s fifty day simple moving average is $338.43 and its 200 day simple moving average is $335.78. The firm has a market capitalization of $328.56 billion, a P/E ratio of 15.72, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group’s payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.